Intersect Ent Contact Us
Localized SteroidReleasing Sinus Implant Intersect ENT
WEBTRANSFORMING PATIENT CARE. We are committed to offering integrated technologies that are less invasive and more cost-effective for the millions suffering from chronic rhinosinusitis. Intersect ENT's bioabsorbable, sustained drug release platform improves …
See Also: Tech Support Preview / Show details
Intersect ENT Wikipedia
Intersect ENT, a subsidiary of Medtronic, is a health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Intersect ENT is best known for developing the first bioabsorbable drug-eluting sinus stent PROPEL, which delivers anti-inflammatory medication directly to the sinuses. The company holds over 20 issued patents in the United States and mor…
Founded: 2003, Series A funding 2006Revenue: $115 Million (2019)Number of employees: 400See Also: Health Preview / Show details
Intersect ENT, Inc. in Menlo Park, CA 94025 650641
WEBIntersect ENT, Inc. is located at 1555 Adams Dr in Menlo Park, California 94025. Intersect ENT, Inc. can be contacted via phone at 650-641-2100 for pricing, hours and directions. …
See Also: Phone Number Preview / Show details
Intersect ENT, Inc., Now Part of Medtronic LinkedIn
WEBIntersect ENT (Nasdaq:XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based …
See Also: Tech Support Preview / Show details
Intersect ENT Facebook
WEBIntersect ENT, Menlo Park, California. 754 likes. Intersect ENT is an innovator in localized steroid releasing technology for ENT conditions.
Rating: 5/5(10)Followers: 806
See Also: Tech Support Preview / Show details
Medtronic to Acquire Intersect ENT Aug 6, 2021
WEBAug 6, 2021 · DUBLIN and MENLO PARK, Calif., Aug. 6, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive …
See Also: Tech Support Preview / Show details
Medtronic completes acquisition of Intersect ENT May 13, 2022
WEBAug 6, 2021 · Acquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio. DUBLIN and MENLO PARK, Calif., May 13, 2022 /PRNewswire/ -- …
See Also: Phone Number Preview / Show details
Intersect ENT, Inc. Company Profile Menlo Park, CA Competitors
WEBFind company research, competitor information, contact details & financial data for Intersect ENT, Inc. of Menlo Park, CA. Get the latest business insights from Dun & …
See Also: Contact Support Preview / Show details
PROPEL Sinus Implants For Chronic Sinusitis Intersect …
WEBPhone: Orders and customer inquiries 0011-1-650-641-2147 Fax: 0011-1-650-641-2073 Email: [email protected] Web: IntersectENT.co.uk EMERGO EUROPE Prinsessegracht 20
See Also: Phone Number Preview / Show details
Benefits of Our Clinically Proven Sinus Implants PROPEL
WEBIntersect ENT has a complete portfolio of implants indicated for use following ESS ; Intersect ENT offers a family of 3 steroid-eluting implants under one brand: PROPEL; The PROPEL family of steroid-eluting …
See Also: Phone Number Preview / Show details
Intersect ENT Crunchbase Company Profile & Funding
WEBCompany Type For Profit. Contact Email [email protected]. Phone Number 650-641-2100. Intersect ENT Inc. (formerly Sinexus) is a medical device company …
See Also: Phone Number Preview / Show details
Intersect ENT, Inc YouTube
WEBThe purpose of this channel is to help create awareness about sinusitis and treatment options for the disease.
See Also: Atm Preview / Show details
Intersect ENT® Releases New System for Balloon Sinus Dilation
WEBIntersect ENT®, Inc. has officially released the VenSure™ Balloon Sinus Dilation System and Cube™ 4D Navigation System with VirtuEye™ photo registration. These products …
See Also: Navigation Preview / Show details
Medtronic completes acquisition of Intersect ENT PR Newswire
WEBMay 13, 2022 · As a result of the close of the transaction announced on Aug. 6, 2021, Medtronic has acquired Intersect ENT's PROPEL™ and SINUVA™ (mometasone …
See Also: Phone Number Preview / Show details
Intersect ENT Announces Launch of the New Straight Delivery …
WEBFeb 11, 2021 · Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today ann
See Also: Tech Support Preview / Show details
Intersect ENT Dr. David Seidman ENT Queens New York
WEBGet In Touch. Center Of Cosmetic Nasal Surgery: 718-805-9500. Manhattan Otolaryngology: 212-861-3700. Email: [email protected].
See Also: Phone Number Preview / Show details
Medtronic to Acquire Intersect ENT PR Newswire
WEBAug 6, 2021 · Medtronic's acquisition of Intersect ENT expands the company's portfolio of products used during ear, nose, and throat procedures. The complementary product …
See Also: Phone Number Preview / Show details